The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy
about
When the most potent combination of antibiotics selects for the greatest bacterial load: the smile-frown transitionModeling infectious disease dynamics in the complex landscape of global healthEvolutionary biology and genetic techniques for insect controlPharmacokinetic and pharmacodynamic considerations in antimalarial dose optimizationEvolutionary rescue: linking theory for conservation and medicineTowards the just and sustainable use of antibioticsEnhanced transmission of drug-resistant parasites to mosquitoes following drug treatment in rodent malariaAggressive chemotherapy and the selection of drug resistant pathogensRapid response to selection, competitive release and increased transmission potential of artesunate-selected Plasmodium chabaudi malaria parasitesA population model evaluating the consequences of the evolution of double-resistance and tradeoffs on the benefits of two-drug antibiotic treatmentsA population genetic model for the initial spread of partially resistant malaria parasites under anti-malarial combination therapy and weak intrahost competitionExisting Infection Facilitates Establishment and Density of Malaria Parasites in Their Mosquito VectorSurveillance of the Sensitivity towards Antiparasitic Bath-Treatments in the Salmon Louse (Lepeophtheirus salmonis)Integrating Antimicrobial Therapy with Host Immunity to Fight Drug-Resistant Infections: Classical vs. Adaptive TreatmentAdaptive Landscape by Environment Interactions Dictate Evolutionary Dynamics in Models of Drug ResistanceDoes High-Dose Antimicrobial Chemotherapy Prevent the Evolution of Resistance?A model-guided analysis and perspective on the evolution and epidemiology of antibiotic resistance and its futureEvolutionary medicine: its scope, interest and potentialCancer in light of experimental evolutionT Cell Adaptive Immunity Proceeds through Environment-Induced Adaptation from the Exposure of Cryptic Genetic VariationThe role of evolutionary biology in research and control of liver flukes in Southeast Asia.Applying evolutionary biology to address global challenges.Fitness estimates from experimental infections predict the long-term strain structure of a vector-borne pathogen in the field.Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infectionsEmergence of resistance to atovaquone-proguanil in malaria parasites: insights from computational modeling and clinical case reportsPhages limit the evolution of bacterial antibiotic resistance in experimental microcosms.Establishment of macrocyclic lactone resistant Dirofilaria immitis isolates in experimentally infected laboratory dogs.Evolution of virulence in emerging epidemics.Antibiotic resistance: a primer and call to actionOpinion: Control vs. eradication: applying infectious disease treatment strategies to cancer.The value of monitoring to control evolving populationsIn the light of evolution V: cooperation and conflict.Clonal expansion during Staphylococcus aureus infection dynamics reveals the effect of antibiotic intervention.Exposure to phages has little impact on the evolution of bacterial antibiotic resistance on drug concentration gradients.Public health evolutionary biology of antimicrobial resistance: priorities for interventionUnderstanding genetic variation in in vivo tolerance to artesunate: implications for treatment efficacy and resistance monitoringA window of opportunity to control the bacterial pathogen Pseudomonas aeruginosa combining antibiotics and phages.Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance.Is selection relevant in the evolutionary emergence of drug resistance?The fitness of drug-resistant malaria parasites in a rodent model: multiplicity of infection
P2860
Q21145725-07CB72A5-9995-43C9-85E9-AD325C922A1EQ24277713-6469B84F-AD2B-411F-860B-E188020A85C8Q26315549-023990BC-EF31-4020-8FA6-99931D3B2473Q26830528-A399D20B-047B-49E5-9A1C-92533FAF831CQ26862297-D9070D49-1A9D-4534-A124-8787EB3F6BEFQ28067846-A18D8A8C-759B-4577-A753-57F2D5AF65C8Q28484134-3EAB43A9-8DDE-474C-859F-D85A26608C95Q28533328-027E1BD9-4384-47C8-A74A-54CEFAB1F8E9Q28538245-B4079BF9-77D1-4E21-80FC-C2570434E9DCQ28539364-495E1D81-F865-4183-806A-7C75ACEBB236Q28540567-5E28EAD5-7C02-40B0-86D5-693759204C2AQ28546601-C335B3D0-8469-4792-84DB-81D768EC2E14Q28550266-3A76D94E-7783-4761-B5E5-2CCBDEBAD994Q28551361-33C0E958-011E-4D76-A834-416144A934DDQ28552806-035CBB34-865C-49DC-81B2-2EBE508CDF75Q28552950-EF2D6B44-63F5-41E4-B852-2F3DFC61351DQ28655580-F761A8EB-E5AF-4AEA-AFDD-80C2DD832077Q28715053-257E3BCC-C11B-4A2A-AD73-38E7B9710E3BQ28727500-09755AC2-138E-419F-8EF9-BD5285EEF126Q28732174-96B992C8-222B-4F34-8A8C-B9AAEADD3FCDQ30250267-F55EB6E8-D855-4BA9-8CA0-8AB4CFFD095FQ30387318-515756F1-47C5-402D-9AA3-FBFFDB4B3526Q33686914-BFB22465-5D72-4330-9A7B-A98BC26D1BF6Q33767602-15FCFBDE-4552-4E60-8C54-4412C07E12A3Q34058304-F225E3B5-D471-4C67-9EBB-506EB673F0BDQ34426663-808D3FDA-B89E-45D8-9E2A-E35E74F64861Q34492057-8EE63165-9155-42B3-9907-366EF23AEE2EQ34629148-BC44BD4C-756E-498F-81FB-AD052A967431Q34765528-9DF113ED-66CA-4880-8064-3988EBE45AA4Q35037877-1ECD8B2C-8618-4899-825D-555AA8AE5C1DQ35038019-5BA8DFD4-438D-490A-B76B-B74222DCFAB0Q35092419-84BA455F-62B2-46C3-A948-50B43AF3C7F8Q35105644-F9678769-295D-445E-910D-BB35E11E9013Q35130454-F9E5372E-2C9A-4FCC-899D-800DD1116C95Q35236703-414CEAFC-2944-457C-BB5C-7DA1DB2B9D56Q35236718-1E3D618A-8960-4609-BBC3-34EE134EB08BQ35279671-AE644EAE-D1DA-4FD4-8C89-7D2EA167DB96Q35699612-9C832CC6-ACCC-48C1-B797-079FA1A8CA3AQ35826386-BF02AEA7-7028-42EC-B5EC-DE326D24C737Q35831322-C171CB78-7770-40BB-8EBF-EFF3C6CB3B65
P2860
The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy
@ast
The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy
@en
type
label
The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy
@ast
The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy
@en
prefLabel
The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy
@ast
The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy
@en
P2860
P50
P356
P1476
The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy
@en
P2860
P304
10871-10877
P356
10.1073/PNAS.1100299108
P407
P478
108 Suppl 2
P577
2011-06-20T00:00:00Z